Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 July 2019 | Story Zamuxolo Feni | Photo Johan Roux
Photo-MedicalStudents
Head of the University of the Free State School of Clinical Medicine Prof Nathaniel Mofolo (left) standing with the medical students who were about to board one of the newly-introduced vehicles that will ferry students to and from their work stations for their practical training.

In an effort to ensure the safety and convenience of undergraduate students doing their practical training at clinical platforms in Bloemfontein, the University of the Free State (UFS) – in collaboration with the Free State Department of Health (DoH) – has initiated a programme to transport undergraduate students to and from the respective clinical platforms.

UFS and Free State Department of Health joining forces for student safety

The Department of Health is providing a fleet of six minibuses and Kombis, as well as drivers for the vehicles. The transport is available to the students at no cost, from 06:00 to 23:00 every day as well as on weekends and public holidays.

Prof Nathaniel Mofolo, Head of the School of Clinical Medicine at the UFS, said, “This is the first initiative of its kind that the university has had with the provincial Department of Health. We are thankful for this initiative, as it will greatly assist in securing the safety of our students.”

More students from Health Sciences set to benefit

The initiative started on the morning of 8 July 2019, when groups of medical students boarded mini-buses and Kombis to the Pelonomi Hospital, National Hospital, Free State Psychiatric Complex, and the Mangaung University Community Partnership Programme (MUCPP).

Prof Mofolo said there was a firm intention from both parties to extend the programme to undergraduate students in the School of Nursing, as well as to students in the School of Allied Health Professions during August 2019.

According to Prof Mofolo, the decision to implement the transport programme was taken after student safety and wellness concerns were taken into consideration. “Although students can make use of the service on a voluntary basis, we have already received feedback that the service is being put to good use,” said Prof Mofolo.

The safety of undergraduate students doing their practical training at Pelonomi Hospital has been in the spotlight last month after the attempted rape of a medical intern, as well as the robbery of a medical officer in the parking area of the hospital. “We are hopeful that the transport programme will prevent the occurrence of similar incidents,” said Prof Mofolo.

Over the past month, the UFS, the DoH, and the executive management of Pelonomi Hospital have been working tirelessly to ensure the implementation of an agreed Safety and Security Plan, hence placing the safety of students, staff, and patients first.

 

News Archive

Nobel Prize-winner presents first lecture at Vice-Chancellor’s prestige lecture series
2017-11-17


 Description: Prof Levitt visit Tags: Prof Levitt visit

At the first lecture in the UFS Vice Chancellor’s Prestige Lecture series,
were from the left: Prof Jeanette Conradie, UFS Department of Chemistry;
Prof Michael Levitt, Nobel Prize-winner in Chemistry, biophysicist and
professor in structural biology at Stanford University; Prof Francis Petersen,
UFS Vice-Chancellor and Rector; and Prof Corli Witthuhn,
UFS Vice-Rector: Research. 
Photo: Johan Roux

South African born biophysicist and Nobel Prize-winner in Chemistry, Prof Michael Levitt, paid a visit to the University of the Free Sate (UFS) as part of the Academy of Science of South Africa’s (ASSAf) Distinguished Visiting Scholars’ Programme. 

Early this week the professor in structural biology at Stanford University in the US presented a captivating lecture on the Bloemfontein Campus on his lifetime’s work that earned him the Nobel Prize in 2013. His lecture launched the UFS Vice-Chancellor’s Prestige Lecture series, aimed at knowledge sharing within, and beyond our university boundaries. 

Prof Levitt was one of the first researchers to conduct molecular dynamics simulations of DNA and proteins and developed the first software for this purpose. He received the prize for Chemistry, together with Martin Karplus and Arieh Warshel, “for the development of multiscale models for complex chemical systems”.

Attending the lecture were members of UFS management, academic staff from a range of faculties and other universities as well as young researchers. “Multiscale modelling is very much based on something that makes common sense,” Prof Levitt explained. “And that is to makes things as simple as possible, but not simpler. Everything needs to have the right level of simplicity, that is not too simple, but not too complicated.”  

An incredible mind
Prof Levitt enrolled for applied mathematics at the University of Pretoria at the age of 15. He visited his uncle and aunt in London after his first-year exams, and decided to stay on because they had a television, he claims. A series on molecular biology broadcast on BBC, sparked an interest that would lead Prof Levitt via Israel, and Cambridge, to the Nobel Prize stage – all of which turned out to be vital building blocks for his research career. 

Technology to the rescue
The first small protein model that Prof Levitt built was the size of a room. But that exercise led to the birth of multiscale modelling of macromolecules. For the man on the street, that translates to computerised models used to simulate protein action, and reaction. With some adaptations, the effect of medication can be simulated on human protein in a virtual world. 

“I was lucky to stand on the shoulder of giants,” he says about his accomplishments, and urges the young to be good and kind. “Be passionate about what you do, be persistent, and be original,” he advised.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept